help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on June 28, 2007, doi:10.1165/rcmb.2006-0404OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0404OCv1
37/5/606    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hauber, H.-P.
Right arrow Articles by Zabel, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hauber, H.-P.
Right arrow Articles by Zabel, P.
American Journal of Respiratory Cell and Molecular Biology. Vol. 37, pp. 606-616, 2007
© 2007 American Thoracic Society
DOI: 10.1165/rcmb.2006-0404OC

Effect of Dexamethasone and ACC on Bacteria-Induced Mucin Expression in Human Airway Mucosa

Hans-Peter Hauber1, Torsten Goldmann2, Ekkehard Vollmer2, Barbara Wollenberg3 and Peter Zabel1

1 Medical Clinic, and 2 Department of Pathology, Research Center Borstel, Borstel, Germany; and 3 ENT Department, University Hospital Schleswig Holstein Campus Lübeck, Lübeck, Germany

Correspondence and requests for reprints should be addressed to Hans-Peter Hauber, M.D., Medical Clinic, Research Center Borstel, Parkallee 35, 23845 Borstel, Germany. E-mail: hphauber{at}web.de

Gram-negative bacteria can stimulate mucin production, but excessive mucus supports bacterial infection and consequently leads to airway obstruction. Therefore, the effect of dexamethasone (DEX) and the antioxidant acetyl-cysteine (ACC) on bacteria-induced mucus expression was investigated. Explanted human airway mucosa and mucoepidermoid cells (Calu-3) were stimulated with lipopolysaccharide (LPS) or PAM3 (a synthetic lipoprotein). DEX or ACC were added to either LPS- or PAM3-stimulated airway mucosa or Calu-3 cells. Mucin mRNA expression (MUC5AC) and total mucus glycoconjugates (mucin protein) were quantified using real-time PCR and periodic acid Schiff staining. LPS and PAM3 significantly increased mucin expression in airway mucosa and Calu-3 cells (P < 0.05). DEX alone had no significant effect on mucin expression in airway mucosa or Calu-3 cells (P > 0.05). In contrast, DEX significantly reduced LPS- and PAM3-induced mucin expression in explanted mucosal tissue and mucin expression in Calu-3 cells (P < 0.05). In explanted human airway mucosa ACC alone significantly increased mucin expression (P < 0.05). In contrast, ACC significantly decreased LPS- and PAM3-induced mucin expression (P < 0.05). In Calu-3 cells ACC alone had no significant effect on mucin expression (P > 0.05). ACC decreased LPS- and PAM3-induced mucin expression, but this effect was not significant (P > 0.05). These data suggest that DEX can effectively reduce bacteria-induced mucin expression in the airways. ACC alone may increase mucin expression in noninfected mucosa, but it decreased bacteria-induced mucin expression. Further studies are warranted to evaluate whether the effect of DEX or ACC is clinically relevant.

Key Words: acetyl-cysteine • dexamethasone • lipoprotein • lipopolysaccharide • mucin







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2007 American Thoracic Society.
  ATS Best of the Web